171 related articles for article (PubMed ID: 34458018)
1. Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of
Zhao H; Zhang J; Fu X; Mao D; Qi X; Liang S; Meng G; Song Z; Yang R; Guo Z; Tong B; Sun M; Zuo B; Li G
PeerJ; 2021; 9():e11880. PubMed ID: 34458018
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma.
Dong H; Zhu L; Sun J; Zhang Y; Cui Q; Wu L; Chen S; Lu J
J Cancer; 2021; 12(20):6242-6253. PubMed ID: 34539897
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of Long Non-coding RNAs and mRNAs in Plasma of Clear Cell Renal Cell Carcinoma Patients Using Microarray and Bioinformatic Analysis.
Zhang B; Chu W; Wen F; Zhang L; Sun L; Hu B; Wang J; Su Q; Mei Y; Cao J; Zheng J; Mou X; Dong H; Lin X; Wang N; Ji H
Front Oncol; 2020; 10():559730. PubMed ID: 33330027
[No Abstract] [Full Text] [Related]
4. Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma.
Zhu Z; He A; Lin L; Xu C; Cai T; Lin J
J Cancer; 2020; 11(22):6591-6600. PubMed ID: 33046980
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Wu J; Leng X; Pan Z; Xu L; Zhang H
Int J Gen Med; 2021; 14():5675-5692. PubMed ID: 34557022
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
9. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
[No Abstract] [Full Text] [Related]
10. The correlation between NEDD4L and HIF-1α levels as a gastric cancer prognostic marker.
Jiang X; Zhang S; Yin Z; Sheng Y; Yan Q; Sun R; Lu M; Zhang Z; Li Y
Int J Med Sci; 2019; 16(11):1517-1524. PubMed ID: 31673244
[TBL] [Abstract][Full Text] [Related]
11. NDFIP allows NEDD4/NEDD4L-induced AQP2 ubiquitination and degradation.
Trimpert C; Wesche D; de Groot T; Pimentel Rodriguez MM; Wong V; van den Berg DTM; Cheval L; Ariza CA; Doucet A; Stagljar I; Deen PMT
PLoS One; 2017; 12(9):e0183774. PubMed ID: 28931009
[TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
Li R; Wang L; Wang X; Geng RX; Li N; Liu XH
Oncol Lett; 2020 Apr; 19(4):2846-2860. PubMed ID: 32218839
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.
Zhao F; Gong X; Liu A; Lv X; Hu B; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1136-1143. PubMed ID: 29175326
[TBL] [Abstract][Full Text] [Related]
14. NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene.
Chen H; Ross CA; Wang N; Huo Y; MacKinnon DF; Potash JB; Simpson SG; McMahon FJ; DePaulo JR; McInnis MG
Eur J Hum Genet; 2001 Dec; 9(12):922-30. PubMed ID: 11840194
[TBL] [Abstract][Full Text] [Related]
15. Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Chen M; Zhang S; Nie Z; Wen X; Gao Y
Front Oncol; 2020; 10():873. PubMed ID: 32547955
[TBL] [Abstract][Full Text] [Related]
16. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Gao X; Yang J; Chen Y
J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
[TBL] [Abstract][Full Text] [Related]
17. Effect of m
Wang J; Zhang C; He W; Gou X
Front Oncol; 2020; 10():3. PubMed ID: 32038982
[No Abstract] [Full Text] [Related]
18. The screening of pivotal gene expression signatures and biomarkers in renal carcinoma.
Ruan H; Li S; Tong J; Cao Q; Song Z; Wang K; Huang Y; Bao L; Chen X; Yang H; Chen K; Zhang X
J Cancer; 2019; 10(25):6384-6394. PubMed ID: 31772671
[TBL] [Abstract][Full Text] [Related]
19. An optimal prognostic model based on gene expression for clear cell renal cell carcinoma.
Xu D; Dang W; Wang S; Hu B; Yin L; Guan B
Oncol Lett; 2020 Sep; 20(3):2420-2434. PubMed ID: 32782559
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma.
Wang Z; Zhang Z; Zhang C; Xu Y
Oncol Lett; 2018 Jun; 15(6):8491-8499. PubMed ID: 29805586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
